<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31375587</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01130-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01130-19</ELocationID><Abstract><AbstractText>Enterovirus B species typically cause a rapid cytolytic infection leading to efficient release of progeny viruses. However, they are also capable of persistent infections in tissues, which are suggested to contribute to severe chronic states such as myocardial inflammation and type 1 diabetes. In order to understand the factors contributing to differential infection strategies, we constructed a chimera by combining the capsid proteins from fast-cytolysis-causing echovirus 1 (EV1) with nonstructural proteins from coxsackievirus B5 (CVB5), which shows persistent infection in RD cells. The results showed that the chimera behaved similarly to parental EV1, leading to efficient cytolysis in both permissive A549 and semipermissive RD cells. In contrast to EV1 and the chimera, CVB5 replicated slowly in permissive cells and showed persistent infection in semipermissive cells. However, there was no difference in the efficiency of uptake of CVB5 in A549 or RD cells in comparison to the chimera or EV1. CVB5 batches constantly contained significant amounts of empty capsids, also in comparison to CVB5's close relative CVB3. During successive passaging of batches containing only intact CVB5, increasing amounts of empty and decreasing amounts of infective capsids were produced. Our results demonstrate that the increase in the amount of empty particles and the lowering of the amount of infective particles are dictated by the CVB5 structural proteins, leading to slowing down of the infection between passages. Furthermore, the key factor for persistent infection is the small amount of infective particles produced, not the high number of empty particles that accumulate.<b>IMPORTANCE</b> Enteroviruses cause several severe diseases, with lytic infections that lead to rapid cell death but also persistent infections that are more silent and lead to chronic states of infection. Our study compared a cytolytic echovirus 1 infection to persistent coxsackievirus B5 infection by making a chimera with the structural proteins of echovirus 1 and the nonstructural proteins of coxsackievirus B5. Coxsackievirus B5 infection was found to lead to the production of a high number of empty viruses (empty capsids) that do not contain genetic material and are unable to continue the infection. Coinciding with the high number of empty capsids, the amount of infective virions decreased. This characteristic property was not observed in the constructed chimera virus, suggesting that structural proteins are in charge of these phenomena. These results shed light on the mechanisms that may cause persistent infections. Understanding events leading to efficient or inefficient infections is essential in understanding virus-caused pathologies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turkki</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Life Sciences, BioMediTech, Tampere University, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laajala</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandesande</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sallinen-Dal Maso</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shroff</LastName><ForeName>Sailee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe4;vneby</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galitska</LastName><ForeName>Ganna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindberg</LastName><ForeName>A Michael</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marjom&#xe4;ki</LastName><ForeName>Varpu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, Division of Cell and Molecular Biology/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland varpu.s.marjomaki@jyu.fi.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">infection kinetics</Keyword><Keyword MajorTopicYN="N">viral nonstructural proteins</Keyword><Keyword MajorTopicYN="N">viral structural proteins</Keyword><Keyword MajorTopicYN="N">virus-host interactions</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31375587</ArticleId><ArticleId IdType="pmc">PMC6798118</ArticleId><ArticleId IdType="doi">10.1128/JVI.01130-19</ArticleId><ArticleId IdType="pii">JVI.01130-19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320&#x2013;1323. doi:10.1126/science.275.5304.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5304.1320</ArticleId><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP. 2000. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271:99&#x2013;108. doi:10.1006/viro.2000.0324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0324</ArticleId><ArticleId IdType="pubmed">10814575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903&#x2013;1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188804</ArticleId><ArticleId IdType="pubmed">7531780</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69:3873&#x2013;3877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189108</ArticleId><ArticleId IdType="pubmed">7538177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW. 1997. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175:697&#x2013;700. doi:10.1093/infdis/175.3.697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.3.697</ArticleId><ArticleId IdType="pubmed">9041347</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. 2001. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 98:15191&#x2013;15196. doi:10.1073/pnas.261452898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.261452898</ArticleId><ArticleId IdType="pmc">PMC65005</ArticleId><ArticleId IdType="pubmed">11734628</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Bergelson JM. 2005. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57:869&#x2013;882. doi:10.1016/j.addr.2005.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2005.01.007</ArticleId><ArticleId IdType="pubmed">15820557</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Shen L, Turner JR, Bergelson JM. 2007. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2:181&#x2013;192. doi:10.1016/j.chom.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.07.003</ArticleId><ArticleId IdType="pmc">PMC2719558</ArticleId><ArticleId IdType="pubmed">18005733</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme-Axford E, Sadovsky Y, Coyne CB. 2013. Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts. J Virol 87:8569&#x2013;8581. doi:10.1128/JVI.00708-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00708-13</ArticleId><ArticleId IdType="pmc">PMC3719791</ArticleId><ArticleId IdType="pubmed">23720726</ArticleId></ArticleIdList></Reference><Reference><Citation>Karjalainen M, Rintanen N, Lehkonen M, Kallio K, Maki A, Hellstrom K, Siljamaki V, Upla P, Marjomaki V. 2011. Echovirus 1 infection depends on biogenesis of novel multivesicular bodies. Cell Microbiol 13:1975&#x2013;1995. doi:10.1111/j.1462-5822.2011.01685.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2011.01685.x</ArticleId><ArticleId IdType="pubmed">21899700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rintanen N, Karjalainen M, Alanko J, Paavolainen L, Maki A, Nissinen L, Lehkonen M, Kallio K, Cheng RH, Upla P, Ivaska J, Marjomaki V. 2012. Calpains promote &#x3b1;2&#x3b2;1 integrin turnover in nonrecycling integrin pathway. Mol Biol Cell 23:448&#x2013;463. doi:10.1091/mbc.e11-06-0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-06-0548</ArticleId><ArticleId IdType="pmc">PMC3268724</ArticleId><ArticleId IdType="pubmed">22160595</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjomaki V, Pietiainen V, Matilainen H, Upla P, Ivaska J, Nissinen L, Reunanen H, Huttunen P, Hyypia T, Heino J. 2002. Internalization of echovirus 1 in caveolae. J Virol 76:1856&#x2013;1865. doi:10.1128/jvi.76.4.1856-1865.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.4.1856-1865.2002</ArticleId><ArticleId IdType="pmc">PMC135881</ArticleId><ArticleId IdType="pubmed">11799180</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenz EJ, Howe CL. 2006. Picornaviruses and cell death. Trends Microbiol 14:28&#x2013;36. doi:10.1016/j.tim.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2005.11.003</ArticleId><ArticleId IdType="pubmed">16337385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 74:10153&#x2013;10164. doi:10.1128/JVI.74.21.10153-10164.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.21.10153-10164.2000</ArticleId><ArticleId IdType="pmc">PMC102054</ArticleId><ArticleId IdType="pubmed">11024144</ArticleId></ArticleIdList></Reference><Reference><Citation>Argo E, Gimenez B, Cash P. 1992. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch Virol 126:215&#x2013;229. doi:10.1007/BF01309696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01309696</ArticleId><ArticleId IdType="pubmed">1326261</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou EK, Sane F, Bertin A, Caloone D, Hober D. 2015. Persistent infection of human pancreatic cells with coxsackievirus B4 is cured by fluoxetine. Antiviral Res 116:51&#x2013;54. doi:10.1016/j.antiviral.2015.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.01.010</ArticleId><ArticleId IdType="pubmed">25655448</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D. 2017. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells. Cell Mol Life Sci doi:10.1007/s00018-017-2567-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2567-0</ArticleId><ArticleId IdType="pmc">PMC11107484</ArticleId><ArticleId IdType="pubmed">28601984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM. 2005. 5&#x2032;-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024&#x2013;7041. doi:10.1128/JVI.79.11.7024-7041.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7024-7041.2005</ArticleId><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty H. 2016. Viruses in type 1 diabetes. Pediatr Diabetes 17 Suppl 22:56&#x2013;64. doi:10.1111/pedi.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12370</ArticleId><ArticleId IdType="pubmed">27411438</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KG, Coyne CB. 2014. Death waits for no man: does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev 25:587&#x2013;596. doi:10.1016/j.cytogfr.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.08.002</ArticleId><ArticleId IdType="pmc">PMC4371850</ArticleId><ArticleId IdType="pubmed">25172372</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson SD, Kim KS, Pirruccello SJ, Tracy S, Chapman NM. 2007. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells. J Gen Virol 88:3031&#x2013;3038. doi:10.1099/vir.0.82710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82710-0</ArticleId><ArticleId IdType="pubmed">17947527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Ragland A, Leser JS, Hofling K, Willian S, Semler BL, Tracy S. 2000. A group B coxsackievirus/poliovirus 5&#x2032; nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 74:4047&#x2013;4056. doi:10.1128/JVI.74.9.4047-4056.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.9.4047-4056.2000</ArticleId><ArticleId IdType="pmc">PMC111918</ArticleId><ArticleId IdType="pubmed">10756016</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L, Essaidi-Laziosi M, Perez-Rodriguez FJ, Piuz I, Geiser J, Krause KH, Huang S, Constant S, Kaiser L, Garcin D, Tapparel C. 2018. Viral chimeras decrypt the role of enterovirus capsid proteins in viral tropism, acid sensitivity and optimal growth temperature. PLoS Pathog 14:e1006962. doi:10.1371/journal.ppat.1006962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006962</ArticleId><ArticleId IdType="pmc">PMC5908207</ArticleId><ArticleId IdType="pubmed">29630666</ArticleId></ArticleIdList></Reference><Reference><Citation>Combelas N, Holmblat B, Joffret ML, Colbere-Garapin F, Delpeyroux F. 2011. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses 3:1460&#x2013;1484. doi:10.3390/v3081460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3081460</ArticleId><ArticleId IdType="pmc">PMC3185806</ArticleId><ArticleId IdType="pubmed">21994791</ArticleId></ArticleIdList></Reference><Reference><Citation>Polacek C, Ekstrom JO, Lundgren A, Lindberg AM. 2005. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Virus Res 113:107&#x2013;115. doi:10.1016/j.virusres.2005.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2005.04.021</ArticleId><ArticleId IdType="pubmed">15964091</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullberg M, Tolf C, Jonsson N, Polacek C, Precechtelova J, Badurova M, Sojka M, Mohlin C, Israelsson S, Johansson K, Bopegamage S, Hafenstein S, Lindberg AM. 2010. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol 84:5868&#x2013;5879. doi:10.1128/JVI.02383-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02383-09</ArticleId><ArticleId IdType="pmc">PMC2876633</ArticleId><ArticleId IdType="pubmed">20375176</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson SD, Chapman NM, Hafenstein S, Tracy S. 2011. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment. J Virol 85:3306&#x2013;3314. doi:10.1128/JVI.01827-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01827-10</ArticleId><ArticleId IdType="pmc">PMC3067837</ArticleId><ArticleId IdType="pubmed">21270163</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagan KJ, Goldberg B, Crowell RL. 1984. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 49:635&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255518</ArticleId><ArticleId IdType="pubmed">6321753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg AM, Crowell RL, Zell R, Kandolf R, Pettersson U. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res 24:187&#x2013;196. doi:10.1016/0168-1702(92)90006-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(92)90006-U</ArticleId><ArticleId IdType="pubmed">1326828</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 79:655&#x2013;660. doi:10.1128/JVI.79.1.655-660.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.655-660.2005</ArticleId><ArticleId IdType="pmc">PMC538729</ArticleId><ArticleId IdType="pubmed">15596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Zhang L, Wu Z, Tien P. 2014. Differential interferon pathway gene expression patterns in rhabdomyosarcoma cells during enterovirus 71 or coxsackievirus A16 infection. Biochem Biophys Res Commun 447:550&#x2013;555. doi:10.1016/j.bbrc.2014.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.04.021</ArticleId><ArticleId IdType="pubmed">24735544</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnak JR, Phillips BA. 1982. Poliovirus empty capsid morphogenesis: evidence for conformational differences between self- and extract-assembled empty capsids. J Virol 41:792&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC256816</ArticleId><ArticleId IdType="pubmed">6284971</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler KL, Yoder JL, Carnegie MS, Ashley RE, Makhov AM, Conway JF, Hafenstein S. 2013. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog 9:e1003240. doi:10.1371/journal.ppat.1003240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003240</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 &#xc5; resolution. Protein Sci 3:1651&#x2013;1669. doi:10.1002/pro.5560031005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560031005</ArticleId><ArticleId IdType="pmc">PMC2142606</ArticleId><ArticleId IdType="pubmed">7849583</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente JO, Lee H, Yoder JD, Shingler KL, Carnegie MS, Yoder JL, Ashley RE, Makhov AM, Conway JF, Hafenstein S. 2013. Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol 87:7637&#x2013;7645. doi:10.1128/JVI.03519-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03519-12</ArticleId><ArticleId IdType="pmc">PMC3700288</ArticleId><ArticleId IdType="pubmed">23637404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Ren J, Gao Q, Hu Z, Sun Y, Li X, Rowlands DJ, Yin W, Wang J, Stuart DI, Rao Z, Fry EE. 2015. Hepatitis A virus and the origins of picornaviruses. Nature 517:85&#x2013;88. doi:10.1038/nature13806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13806</ArticleId><ArticleId IdType="pmc">PMC4773894</ArticleId><ArticleId IdType="pubmed">25327248</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Stuart D. 1997. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743&#x2013;9752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230284</ArticleId><ArticleId IdType="pubmed">9371640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Wang X, Ren J, Porta C, Wenham H, Ekstrom JO, Panjwani A, Knowles NJ, Kotecha A, Siebert CA, Lindberg AM, Fry EE, Rao Z, Tuthill TJ, Stuart DI. 2015. Structure of Ljungan virus provides insight into genome packaging of this picornavirus. Nat Commun 6:8316. doi:10.1038/ncomms9316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9316</ArticleId><ArticleId IdType="pmc">PMC4633645</ArticleId><ArticleId IdType="pubmed">26446437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan TT, Lin MH, Chen DS, Shih C. 1998. A defective interference-like phenomenon of human hepatitis B virus in chronic carriers. J Virol 72:578&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109410</ArticleId><ArticleId IdType="pubmed">9420261</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimmock NJ, Easton AJ. 2014. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals? J Virol 88:5217&#x2013;5227. doi:10.1128/JVI.03193-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03193-13</ArticleId><ArticleId IdType="pmc">PMC4019098</ArticleId><ArticleId IdType="pubmed">24574404</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Lott WB, Lowry K, Jones A, Thu HM, Aaskov J. 2011. Defective interfering viral particles in acute dengue infections. PLoS One 6:e19447. doi:10.1371/journal.pone.0019447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019447</ArticleId><ArticleId IdType="pmc">PMC3084866</ArticleId><ArticleId IdType="pubmed">21559384</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Paul AV, Wimmer E. 2012. Evolution of poliovirus defective interfering particles expressing Gaussia luciferase. J Virol 86:1999&#x2013;2010. doi:10.1128/JVI.05871-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05871-11</ArticleId><ArticleId IdType="pmc">PMC3302396</ArticleId><ArticleId IdType="pubmed">22156535</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell RL, Syverton JT. 1961. The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by coxsackie B3 virus and effect on superinfection. J Exp Med 113:419&#x2013;435. doi:10.1084/jem.113.2.419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.113.2.419</ArticleId><ArticleId IdType="pmc">PMC2137354</ArticleId><ArticleId IdType="pubmed">13696665</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullberg M, Tolf C, Jonsson N, Mulders MN, Savolainen-Kopra C, Hovi T, Van Ranst M, Lemey P, Hafenstein S, Lindberg AM. 2010. Characterization of a putative ancestor of coxsackievirus B5. J Virol 84:9695&#x2013;9708. doi:10.1128/JVI.00071-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00071-10</ArticleId><ArticleId IdType="pmc">PMC2937801</ArticleId><ArticleId IdType="pubmed">20631132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson N, Savneby A, Gullberg M, Evertsson K, Klingel K, Lindberg AM. 2015. Efficient replication of recombinant enterovirus B types, carrying different P1 genes in the coxsackievirus B5 replicative backbone. Virus Genes 50:351&#x2013;357. doi:10.1007/s11262-015-1177-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-015-1177-x</ArticleId><ArticleId IdType="pubmed">25663145</ArticleId></ArticleIdList></Reference><Reference><Citation>Myllynen M, Kazmertsuk A, Marjomaki V. 2016. A novel open and infectious form of echovirus 1. J Virol 90:6759&#x2013;6770. doi:10.1128/JVI.00342-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00342-16</ArticleId><ArticleId IdType="pmc">PMC4944302</ArticleId><ArticleId IdType="pubmed">27194757</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjomaki V, Turkki P, Huttunen M. 2015. Infectious Entry Pathway of Enterovirus B Species. Viruses 7:6387&#x2013;6399. doi:10.3390/v7122945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122945</ArticleId><ArticleId IdType="pmc">PMC4690868</ArticleId><ArticleId IdType="pubmed">26690201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>